PMID- 30853285
OWN - NLM
STAT- MEDLINE
DCOM- 20190503
LR  - 20190503
IS  - 2213-0276 (Electronic)
IS  - 0755-4982 (Linking)
VI  - 48
IP  - 3 Pt 1
DP  - 2019 Mar
TI  - [Dyspnoea in asthma: diagnostic approach].
PG  - 274-281
LID - S0755-4982(19)30039-9 [pii]
LID - 10.1016/j.lpm.2019.01.008 [doi]
AB  - Dyspnoea is a cardinal symptom of asthma and an essential part of assessing 
      control of the disease. Its intensity is variable for the same level of bronchial 
      obstruction, which suggests the involvement of other mechanisms. Therefore, it is 
      extremely important to characterize and measure dyspnoea in asthmatic patients 
      because its profile can be quantitatively and qualitatively modified by disease 
      control, comorbidities and anxiety. Hence the value of using additional tools to 
      ACT and ACQ because the latter do not characterize nor measure specifically 
      dyspnoea in asthma. Different tools can be used in this regard, at rest as the 
      subjective assessment of dyspnoea by scales such as the modified Medical Research 
      Council (mMRC), the New York Heart Association (NYHA) and the Visual Analogue 
      Scale (VAS) or more recently using the Dyspnea-12 and the Multidimensional 
      Dyspnea Profile (MDP) questionnaire, which assesses the sensory and affective 
      dimensions of dyspnoea; and during exercise testing such as the "modified" Borg 
      scale, graduated from 0 to 10, or the VAS. Among the factors contributing to 
      dyspnoea in asthmatic patients, probably bronchial obstruction, increased airway 
      resistance and dynamic hyperinflation play an important role. Despite this, the 
      asthmatic patient's description of dyspnoea may be masked by hyperventilation 
      syndrome or other comorbidities that can easily be detected and treated through 
      educational programs and targeted therapies.
CI  - Copyright (c) 2019 Elsevier Masson SAS. All rights reserved.
FAU - Laveneziana, Pierantonio
AU  - Laveneziana P
AD  - Sorbonne Universite, INSERM, UMRS 1158, neurophysiologie respiratoire 
      experimentale et clinique, 75013 Paris, France; AP-HP, Groupe Hospitalier 
      Pitie-Salpetriere Charles Foix, service des explorations fonctionnelles de la 
      respiration, de l'exercice et de la dyspnee, 75013 Paris, France. Electronic 
      address: pierantonio.laveneziana@psl.aphp.fr.
FAU - Beurnier, Antoine
AU  - Beurnier A
AD  - Universite Paris-Sud, faculte de medecine, universite Paris-Saclay, 94270 Le 
      Kremlin-Bicetre, France; AP-HP, Hopital Bicetre, service de physiologie, 94270 Le 
      Kremlin-Bicetre, France.
LA  - fre
PT  - Journal Article
PT  - Review
TT  - La dyspnee de l'asthmatique : approche diagnostique.
DEP - 20190308
PL  - France
TA  - Presse Med
JT  - Presse medicale (Paris, France : 1983)
JID - 8302490
SB  - IM
MH  - Asthma/*complications
MH  - Dyspnea/*diagnosis/*etiology
MH  - Humans
MH  - Hyperventilation/etiology
EDAT- 2019/03/12 06:00
MHDA- 2019/05/06 06:00
CRDT- 2019/03/12 06:00
PHST- 2018/11/12 00:00 [received]
PHST- 2018/12/20 00:00 [revised]
PHST- 2019/01/31 00:00 [accepted]
PHST- 2019/03/12 06:00 [pubmed]
PHST- 2019/05/06 06:00 [medline]
PHST- 2019/03/12 06:00 [entrez]
AID - S0755-4982(19)30039-9 [pii]
AID - 10.1016/j.lpm.2019.01.008 [doi]
PST - ppublish
SO  - Presse Med. 2019 Mar;48(3 Pt 1):274-281. doi: 10.1016/j.lpm.2019.01.008. Epub 
      2019 Mar 8.